Published in JAMA on May 06, 1983
Protective effect of BCG vaccination in infant Asians: a case-control study. Arch Dis Child (1988) 4.71
Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun (2002) 3.29
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A (2000) 3.07
Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ (1990) 2.08
A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. Am J Public Health (1986) 2.01
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun (1996) 1.98
Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85
Comparison of BCG vaccination at birth and at third month of life. Arch Dis Child (1992) 1.68
Does BCG vaccine prevent tuberculous meningitis? Arch Dis Child (1996) 1.58
BCG vaccination and health care workers. BMJ (1993) 1.19
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS One (2008) 1.09
Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker? Tuberc Res Treat (2015) 1.08
Public health controversies: common characteristics. J Glob Infect Dis (2011) 0.86
Does BCG have a role in tuberculosis control and prevention in the United Kingdom? Arch Dis Child (2006) 0.84
Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan. PLoS One (2012) 0.80
An epidemic of primary tuberculosis in a Canadian aboriginal community. Can J Infect Dis (1991) 0.80
BCG vaccination at three different age groups: response and effectiveness. J Immune Based Ther Vaccines (2005) 0.78
A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol (1996) 20.25
Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med (1978) 11.42
A critical appraisal of the quality of quality-of-life measurements. JAMA (1994) 9.10
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ (1999) 8.93
The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med (1985) 8.55
High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol (1990) 8.28
Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther (1981) 7.33
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol (1995) 6.94
The risk of determining risk with multivariable models. Ann Intern Med (1993) 6.45
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med (1991) 6.07
Typhoid fever in children aged less than 5 years. Lancet (1999) 6.00
Variability in radiologists' interpretations of mammograms. N Engl J Med (1994) 5.96
Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA (1995) 5.94
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet (1997) 4.56
Trial of calcium to prevent preeclampsia. N Engl J Med (1997) 3.69
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med (1992) 3.64
Academic calculations versus clinical judgments: practicing physicians' use of quantitative measures of test accuracy. Am J Med (1998) 3.36
Problems of comorbidity in mortality after prostatectomy. JAMA (1992) 3.27
Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA (1999) 3.07
An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA (1979) 3.03
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis (1974) 3.01
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study. Arch Dis Child (2005) 2.59
Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication. Clin Pharmacol Ther (1976) 2.53
Cholera in India: an analysis of reports, 1997-2006. Bull World Health Organ (2010) 2.52
An analysis of diagnostic reasoning. 3. The construction of clinical algorithms. Yale J Biol Med (1974) 2.44
Context bias. A problem in diagnostic radiology. JAMA (1996) 2.42
Scientific and clinical problems in indexes of functional disability. Ann Intern Med (1986) 2.41
An educational intervention for altering water-sanitation behaviors to reduce childhood diarrhea in urban Bangladesh. II. A randomized trial to assess the impact of the intervention on hygienic behaviors and rates of diarrhea. Am J Epidemiol (1987) 2.38
Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. JAMA (1998) 2.37
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA (1999) 2.34
The qualification period. J Clin Epidemiol (1991) 2.33
Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol (1995) 2.32
A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med (1990) 2.32
Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study. Clin Pharmacol Ther (1971) 2.28
A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med (1984) 2.27
Claims of equivalence in medical research: are they supported by the evidence? Ann Intern Med (2000) 2.27
Twenty-four-hour recall, knowledge-attitude-practice questionnaires, and direct observations of sanitary practices: a comparative study. Bull World Health Organ (1987) 2.24
Serum cotinine concentration and self-reported smoking during pregnancy. Am J Epidemiol (1998) 2.15
Coding ordinal independent variables in multiple regression analyses. Am J Epidemiol (1987) 2.15
A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.10
Methodologic standards and contradictory results in case-control research. Am J Med (1979) 2.09
Clinical biostatistics. XLIV. A survey of the research architecture used for publications in general medical journals. Clin Pharmacol Ther (1978) 2.07
T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics. Circulation (1982) 2.06
Clinical biostatistics. XLI. Hard science, soft data, and the challenges of choosing clinical variables in research. Clin Pharmacol Ther (1977) 2.04
The impact of ethnicity, family income, and parental education on children's health and use of health services. Am J Public Health (1999) 2.02
A collection of 56 topics with contradictory results in case-control research. Int J Epidemiol (1988) 2.02
A new clinical prognostic staging system for acute pancreatitis. Am J Med (1993) 2.02
Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J Infect Dis (1998) 2.01
Impact of measles vaccination on childhood mortality in rural Bangladesh. Bull World Health Organ (1990) 1.95
The 'chagrin factor' and qualitative decision analysis. Arch Intern Med (1985) 1.94
Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med (1990) 1.93
Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet (1979) 1.92
An additional basic science for clinical medicine: II. The limitations of randomized trials. Ann Intern Med (1983) 1.87
Clinical biostatistics. XXV. A survey of the statistical procedures in general medical journals. Clin Pharmacol Ther (1974) 1.87
High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg (1996) 1.86
An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis (2001) 1.86
Double standards, scientific methods, and epidemiologic research. N Engl J Med (1982) 1.81
The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol (1998) 1.81
Clinical biostatistics. XXXIX. The haze of Bayes, the aerial palaces of decision analysis, and the computerized Ouija board. Clin Pharmacol Ther (1977) 1.80
Prevalence and predictors of the prone sleep position among inner-city infants. JAMA (1998) 1.74
An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA (1979) 1.65
Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol (1990) 1.63
Measurement of lower limb alignment using long radiographs. J Bone Joint Surg Br (1991) 1.58
Current problems and future challenges in randomized clinical trials. Circulation (1984) 1.57
An analysis of Berkson's bias in case-control studies. J Chronic Dis (1986) 1.53
Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Clin Pharmacol Ther (1975) 1.52
Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis (1970) 1.51
Complications of peripheral arteriography: a new system to identify patients at increased risk. J Vasc Surg (1995) 1.50
The problems of the "problem-oriented medical record". Ann Intern Med (1973) 1.50
Clinical biostatistics. XX. The epidemiologic trohoc, the ablative risk ratio, and "retrospective" research. Clin Pharmacol Ther (1973) 1.50
The role of diagnostic inconsistency in changing rates of occurrence for coronary heart disease. J Clin Epidemiol (1992) 1.50
On white-coat effects and the electronic monitoring of compliance. Arch Intern Med (1990) 1.48
Joseph Goldberger: an unsung hero of American clinical epidemiology. Ann Intern Med (1994) 1.47
B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J Infect Dis (1987) 1.47
A bibliography of publications on observer variability (final installment). J Clin Epidemiol (1992) 1.47
An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J Biol Med (1973) 1.47
Breast feeding as a determinant of severity in shigellosis. Evidence for protection throughout the first three years of life in Bangladeshi children. Am J Epidemiol (1986) 1.46
Clinical utility of endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (1997) 1.45
Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children. Am J Epidemiol (2001) 1.45
Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials? Rev Infect Dis (1984) 1.44
Bootstraps and jackknives: new, computer-intensive statistical tools that require no mathematical theories. J Investig Med (1998) 1.43
An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med (1983) 1.43
Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. JAMA (1966) 1.42
A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. N Engl J Med (1969) 1.42
The problem of "protopathic bias" in case-control studies. Am J Med (1980) 1.41
Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine (1996) 1.39
On exorcizing the ghost of Gauss and the curse of Kelvin. MD Comput (1992) 1.39
Coffee and pancreatic cancer. The problems of etiologic science and epidemiologic case-control research. JAMA (1981) 1.37
Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size. Clin Pharmacol Ther (1975) 1.36
The 'epidemiologic necropsy'. Unexpected detections, demographic selections, and changing rates of lung cancer. JAMA (1987) 1.35
Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. J Clin Microbiol (1999) 1.35
Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis (1979) 1.34
New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. JAMA (1989) 1.34
Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer (1996) 1.31
Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion. N Engl J Med (1999) 1.29
An additional basic science for clinical medicine: I. The constraining fundamental paradigms. Ann Intern Med (1983) 1.29
Clinical effects of recurrent attacks of acute rheumatic fever: a prospective epidemiologic study of 105 episodes. J Chronic Dis (1967) 1.28
Monte Carlo methods in clinical research: applications in multivariable analysis. J Investig Med (1997) 1.28